The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer.
The European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS) established a joint task force with the purpose to develop clinical evidence-based guidelines on evaluation of fitness for radical therapy in patients with lung cancer. The following topics were discussed, and are summarized in the final report along with graded recommendations: Cardiologic evaluation before lung resection; lung function tests and exercise tests (limitations of ppoFEV1; DLCO: systematic or selective?; split function studies; exercise tests: systematic; low-tech exercise tests; cardiopulmonary (high tech) exercise tests); future trends in preoperative work-up; physiotherapy/rehabilitation and smoking cessation; scoring systems; advanced care management (ICU/HDU); quality of life in patients submitted to radical treatment; combined cancer surgery and lung volume reduction surgery; compromised parenchymal sparing resections and minimally invasive techniques: the balance between oncological radicality and functional reserve; neoadjuvant chemotherapy and complications; definitive chemo and radiotherapy: functional selection criteria and definition of risk; should surgical criteria be re-calibrated for radiotherapy?; the patient at prohibitive surgical risk: alternatives to surgery; who should treat thoracic patients and where these patients should be treated?
Brunelli
Alessandro
A
Division of Thoracic Surgery, Umberto I Regional Hospital, Ancona, Italy. alexit_2000@yahoo.com
Charloux
Anne
A
Bolliger
Chris T
CT
Rocco
Gaetano
G
Sculier
Jean-Paul
JP
Varela
Gonzalo
G
Licker
Marc
M
Ferguson
Mark K
MK
Faivre-Finn
Corinne
C
Huber
Rudolf Maria
RM
Clini
Enrico M
EM
Win
Thida
T
De Ruysscher
Dirk
D
Goldman
Lee
L
D006801:Humans; D000465:Algorithms; D003131:Combined Modality Therapy; D019317:Evidence-Based Medicine; D005080:Exercise Test; D006305:Health Status Indicators; D008175:Lung Neoplasms / Q000503:physiopathology / Q000601:surgery / Q000628:therapy; D012129:Respiratory Function Tests; D018570:Risk Assessment / Q000379:methods